Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH for idiopathic short stature (real-world observational study)
ChiCTR2400089255Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Change in height SDS at 1 year and 2 years after treatment. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on ChiCTR2400089255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089255.